McCaul Childhood Cancer Provisions Pass U.S. House
WASHINGTON, D.C. – Today, Chairman Michael McCaul (TX-10) applauds the U.S. House passage of two health provisions he drafted to address childhood cancer, which were included in the 21st Century Cures Act.
The U.S. House of Representatives passed an updated 21st Century Cures Act to accelerate the discovery, development, and delivery of promising new treatments and cures tailored to individuals, rather than one-size-fits-all treatments. It also allocates an additional $4.8 billion in research funding to the National Institute of Health and $550 million to the Food and Drug Administration in order to find cures to diseases that affect all Americans.
“I applaud the passage of the 21st Century Cures Act, which includes two provisions I spearheaded to fight against childhood cancer,” McCaul said. “One incentivizes the development of new treatments for children with rare pediatric diseases through the reauthorization of the Creating Hope Act. The other includes key provisions of the Andrea Sloan CURE Act to expand patient access to potentially lifesaving treatments through the Food and Drug Administration’s compassionate use process. It is a privilege to work for better treatments for patients and families in the 10th Congressional district and across America.”
The 21st Century Cures Act will now head to the Senate for their consideration.
Congressman Michael McCaul has represented the 10th District of Texas since 2004. Currently, he serves as Chairman of the House Committee on Homeland Security and senior member on the House Foreign Affairs Committee.